• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Radiology Classics

Combination mammography and breast tomosynthesis improves breast cancer screening [Classics Series]

byDeepti Shroff Karhade
August 16, 2022
in Radiology Classics, The Classics
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials

1. The addition of breast tomosynthesis to digital mammography in breast cancer screening improved lesion conspicuity, thereby significantly increasing the rate of cancer detection and the overall positive predictive value of screening.

2. The rate of patient recall for further workup of a positive screen was significantly reduced with the addition of tomosynthesis.

Original Date of Publication: June 2014

Study Rundown: Breast cancer screening entails yearly mammography and clinical breast exam for women aged 50-70 years, among whom it has been shown to reduce mortality. However, mammography alone suffers from a limited positive predictive value, with an excess of false-positive results believed to be due to overlapping breast tissue. Breast tomosynthesis (BT) was developed to offset this limitation. By acquiring multiple low-dose images of the breast at focal planes of varying depth and reconstructing a single image or depth stacked series of images, BT reduces the “noise” of overlapping densities within the breast to more easily highlight true abnormalities. As imaging technology has progressed with large-field, fast-reading detectors, BT has now become feasible in routine practice, and the referenced study sought to examine how large-scale combination of mammography and BT compares to mammography alone in improving upon the specificity of breast cancer screening. In a retrospective review of nearly a half million screening examinations performed before and after the introduction of combined mammography and BT in routine practice, the combination technique significantly increased the positive predictive value of a positive screening examination from 4.3% to 6.4%, and of a subsequent biopsy from 24.2% to 29.2%. This improvement was reflected in an increase in the cancer detection rate at screening from 4.2 by mammography alone to 5.4 per 1000 examinations by the combined method. Additionally, the combination of mammography and BT reduced the overall recall rate, or the proportion of patients in whom a positive screen necessitated further workup, from 107 to 91 per 1000 examinations. Together, these findings suggested that the addition of BT to routine breast cancer screening may improve screening specificity, thereby reducing unnecessary interventions due to false-positive results. However, a direct determination of sensitivity and specificity could not be calculated as the dataset did not include patient-level information on the occurrence of interval cancers. The study was additionally limited by its retrospective nature and inherent lack of randomization, introducing the potential for selection bias and differences in baseline patient characteristics to influence the results obtained.

Click to read the study in JAMA

In-Depth [retrospective cohort]: This retrospective trial was conducted at 13 separate sites over two separate periods, one prior to the introduction of BT at each institution (one year in duration), and the other following the start of standard screening with combined digital mammography and BT (average duration of 17 months). Notably, only two sites were able to replace all equipment with tomography capable devices at once, while others maintained a hybrid environment in which mammography alone was still used after the transition. A total of 454 850 screening examinations were included in the primary analysis, read by 139 radiologists across all sites, with 61.8% performed during the first period (mammography alone), and 38.2% performed during the second period (mammography + BT). Comparing those studies performed prior to the introduction of BT to mammographic screening, a specific set of metrics was tabulated to compare the efficacy of mammography with and without BT: The patient recall rate, or proportion of patients in whom a positive screen necessitated additional imaging; the cancer detection rate, or proportion of patients in whom a positive screen detected a true cancer, and the positive predictive value for both patient recall and for biopsies performed as a result of a screening examination. For mammography alone, the rate of patient recall was 107 per 1000 screens as compared to 91 per 1000 screens for mammography + BT, resulting in a decrease in the recall rate of -16 (95%CI -18 to -14; p <0.001) per 1000 screens. The difference in biopsy rate between mammography without and with BT was +1.3 (95%CI 0.4-2.1; p = 0.004) per 1000 screens. The overall cancer detection rate (n=815 invasive cancers, n=392 ductal carcinoma in situ) for mammography alone was 4.2 per 1000 screens, while it increased to 5.4 per 1000 screens with the addition of tomography, resulting in an increase of 1.2 (95%CI 0.8-1.6; p <0.001) per 1000 screens. When considering invasive cancers alone, the net increase in cancer detection rate was unchanged. The PPV for recall for mammography alone was 4.3% versus 6.4% with the addition of BT, for an overall increase of 2.1% (95%CI 1.7-2.5% p <0.001), while for biopsy, the net increase in PPV was 5.0% (95%CI 3.0-7.0%; p <0.001). A secondary analysis was performed using examinations the second period alone, comparing mammograms performed without BT to those performed with BT in an effort to address the potential for selection bias to affect the results given the hybrid nature of the transition at many sites. A statistically significant improvement in cancer detection with mammography + BT was found (p <0.001), consistent with those findings from the primary analysis.

RELATED REPORTS

#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

Religious-based interventions improve illness perception in breast cancer patients

Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, et al. Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography. The Journal of The American Medical Association. 2014 Jun 25;311(24):2499–2507.

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: biopsyBreast Cancermammographytomosynthesis
Previous Post

Internet cognitive behavioral therapy may improve insomnia in chronic pain patients

Next Post

Tiotropium bromide safe and effective in treating early childhood wheezing

RelatedReports

#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation
StudyGraphics

#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation

January 31, 2023
#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer
StudyGraphics

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

January 24, 2023
Palliative care consultation linked to lower deaths by failed code resuscitation
Oncology

Religious-based interventions improve illness perception in breast cancer patients

January 9, 2023
Early palliative care may improve survival in advanced cancer
Wellness

Wellness Check: Spirituality

January 5, 2023
Next Post
Hypertonic saline may be effective in bronchiolitis

Tiotropium bromide safe and effective in treating early childhood wheezing

#VisualAbstract: Capivasertib in addition to fulvestrant improves  progression-free survival in ER⁺ advanced breast cancer

#VisualAbstract: Capivasertib in addition to fulvestrant improves progression-free survival in ER⁺ advanced breast cancer

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

PI-RADS version 2: Standardized acquisition, interpretation, and reporting of prostate MRI [Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gender-affirming hormones improve psychosocial functioning in transgender youth
  • Left atrial reservoir strain improves ischemic stroke risk prediction in low-risk patients
  • #VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options